drugset / Trial / NCT02633371

A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults

NCT02633371

NaSingle-groupOpen-labelTreatment

Summary

This is a single-center, prospective, open-label, outpatient pilot study evaluating the efficacy and tolerability of oxybutynin gel for axillary hyperhidrosis.

Timeline

Start
2016-02
Primary completion
2016-06
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxybutynin Small molecule 56 mg Topical